Exxon, Chevron Dominate DJIA Wednesday
September 28, 2016: Markets opened slightly higher again Wednesday and both the S&P 500 and the DJIA dipped below the break-even line before a report from Reuters hit the wires, citing sources…
September 28, 2016: Markets opened slightly higher again Wednesday and both the S&P 500 and the DJIA dipped below the break-even line before a report from Reuters hit the wires, citing sources…
The September 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest has increased.
September 20, 2016: Markets opened higher Tuesday as no sector was showing big gains but healthcare stocks the clear leader. Traders and investors are likely trying to position themselves for the markets’…
September 19, 2016: Markets opened higher Monday and while most sectors traded in the green the gains didn’t add up to much. Fresh speculation about an OPEC production freeze pushed oil prices…
Despite recent market headwinds and volatility, there are strong underlying fundamentals among the large cap pharmaceuticals that are continuing to drive them forward.
The August 31 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest has significantly decreased.
September 7, 2016: Markets opened mixed Wednesday following largely unmemorable sessions overseas. European markets await a policy statement from the ECB due Thursday morning. The Beige Book’s release did move equities somewhat…
The August 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest has significantly decreased.
August 24, 2016: Markets opened lower Wednesday and only the Nasdaq Composite made even a brief visit to positive territory during the day’s trading session. Healthcare and materials stocks led the losers…
Medivation has been among the top future biotech mergers for quite some time. The problem is that we still have no idea which company will buy Medivation, nor do we know what…
Credit Suisse has run bullish and bearish scenarios for what the firm feels is a reasonable upside and downside for each of its large cap pharmaceutical stocks.
The July 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest was lower.
The short interest data for the July 29 settlement date are out and it almost feels like short sellers are getting a bit panicked about the market rally.
August 9, 2016: Markets opened higher again Tuesday following the lead of Asian and European exchanges. The productivity report cooled investors’ enthusiasm, though, and afternoon trading saw equities slipping below the break-even…
August 8, 2016: Markets opened higher Monday but turned south shortly after the opening bell and remained in the red for the rest of the day. The dollar gained strength this afternoon…